Tharimmune, Inc. (THAR)
THAR Stock Price Chart
Explore Tharimmune, Inc. interactive price chart. Choose custom timeframes to analyze THAR price movements and trends.
THAR Company Profile
Discover essential business fundamentals and corporate details for Tharimmune, Inc. (THAR) to support your stock research and investment decisions.
Sector
Healthcare
Industry
Biotechnology
IPO Date
12 Jan 2022
Employees
2.00
Website
https://www.tharimmune.comCEO
Randy D. Milby MBA
Description
Tharimmune, Inc., a clinical-stage biotechnology company, engages in the development of therapeutic candidates for rare, inflammatory, and oncologic diseases. The company's pre-clinical immuno-oncology pipeline includes TH104, a product candidate for the treatment of liver-related and other pruritogenic inflammatory conditions; TH3215 and TH0059 that are product candidates used to treat various solid tumors; and TH1940, which targets programmed cell death protein 1 (PD-1). It has a research collaboration and product license agreement with Minotaur Therapeutics, Inc. for the development of proprietary targeted biologics. The company was formerly known as Hillstream BioPharma, Inc. and changed its name to Tharimmune, Inc. in September 2023. Tharimmune, Inc. was incorporated in 2017 and is headquartered in Bridgewater, New Jersey.
THAR Financial Timeline
Browse a chronological timeline of Tharimmune, Inc. corporate events including earnings releases, dividend announcements, and stock splits.
Earnings released on 14 Aug 2025
EPS came in at -$0.64 falling short of the estimated -$0.58 by -10.34%.
Earnings released on 12 May 2025
EPS came in at -$0.99 falling short of the estimated -$0.84 by -17.86%.
Earnings released on 25 Mar 2025
EPS came in at -$2.02 falling short of the estimated -$1.53 by -32.03%.
Earnings released on 7 Nov 2024
EPS came in at -$2.45 .
Earnings released on 9 Aug 2024
EPS came in at -$2.42 .
Stock split effective on 28 May 2024
Shares were split 1 : 15 , changing the number of shares outstanding and the price per share accordingly.
Earnings released on 9 May 2024
EPS came in at -$2.85 .
Earnings released on 21 Mar 2024
EPS came in at -$0.71 surpassing the estimated -$1.25 by +43.20%.
Stock split effective on 21 Nov 2023
Shares were split 1 : 25 , changing the number of shares outstanding and the price per share accordingly.
Earnings released on 7 Nov 2023
EPS came in at -$41.23 falling short of the estimated -$18.74 by -120.01%.
Earnings released on 11 Aug 2023
EPS came in at -$0.16 matching the estimated -$0.16.
Earnings released on 22 May 2023
EPS came in at -$0.23 falling short of the estimated -$0.11 by -109.09%.
Earnings released on 30 Dec 2022
EPS came in at -$57.53 .
Earnings released on 29 Sept 2022
EPS came in at -$69.18 .
Earnings released on 29 Jun 2022
EPS came in at -$53.04 .
Earnings released on 30 Mar 2022
EPS came in at -$104.35 .
Earnings released on 30 Dec 2021
EPS came in at $80.94 .
Earnings released on 29 Sept 2021
EPS came in at -$31.09 .
Earnings released on 29 Jun 2021
EPS came in at -$56.68 .
Earnings released on 31 Mar 2021
EPS came in at -$75.12 .
Earnings released on 31 Dec 2020
EPS came in at -$45.15 .
Earnings released on 30 Sept 2020
EPS came in at -$15.08 .
THAR Stock Performance
Access detailed THAR performance analysis with candlestick charts, real‑time intraday data and historical financial metrics for comprehensive insights.
Explore Related Stocks
Compare companies within the same sector by viewing performance, key financials, and market trends. Select a symbol to access the full profile.